Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
Tiffany Cho-Lam WongJames Yan-Yue FungHerbert H PangCalvin Ka-Lam LeungHoi-Fan LiSui-Ling SinKa-Wing MaBrian Wong-Hoi SheJeff Wing-Chiu DaiAlbert Chi-Yan ChanTan-To CheungChung-Mau LoPublished in: Hepatology (Baltimore, Md.) (2021)
The ITT-LDLT reduced waitlist mortality and allowed an earlier access to transplant. LDLT in patients with high MELD/HRS was feasible, and they had similar perioperative outcomes and better renal recovery, whereas the long-term survival and eGFR were comparable with DDLT. LDLT should be considered for patients with high MELD/HRS, and the application of LDLT should not be restricted with a MELD cutoff.